Skip to footer

New doping charges for Lance Armstrong

Federal prosecutors chose not to pursue a case against the cycling champion earlier this year, but now the U.S. Anti-Doping Agency has filed a formal accusation.  If he's found to have used performance enhancers, he could be banned from sports and have to return his medals.

|
Marcio Jose Sanchez/AP/File
Lance Armstrong preparing for the final leg of the Tour of California in 2009. Now, the cycling champ is facing new doping allegations.
  • By Jim Vertuno The Associated Press

 For Lance Armstrong, the doping allegations aren't going away. In fact, they're starting all over again.

The U.S. Anti-Doping Agency has filed formal charges against the seven-time Tour de France winner, threatening to strip him of his victories in cycling's most prestigious road race.

Armstrong, who forcefully denied the accusations, could face a lifetime ban from the sport if he is found to have used performance-enhancing drugs. The move by USADA immediately bans him from competing in triathlons, which he turned to after he retired from cycling last year.

Armstrong has been dogged by doping allegations since his first Tour victory in 1999, but had hoped his fight to be viewed as a clean champion was finally won after U.S. federal prosecutors closed a two-year criminal probe in February without bringing any charges. Armstrong has said the investigation took a heavy emotional toll and he was relieved when it ended.

But USADA officials insisted they would continue to pursue their own probe into Armstrong and his former teams and doctors, and notified him of the charges in a 15-page letter on Tuesday. Unlike federal prosecutors, USADA isn't burdened by proving a crime occurred, just that there was use of performance-enhancing drugs.

In its letter, USADA said its investigation included evidence dating back to 1996. It also included the new charge that Armstrong blood samples taken in 2009 and 2010 are "fully consistent with blood manipulation including EPO use and/or blood transfusions." Armstrong came out of his first retirement to race in the Tour de France those two years.

Armstrong, who was in France while training for a triathlon, issued a statement dismissing the latest allegations "baseless" and "motivated by spite." Even though he last won the Tour seven years ago, the 40-year-old Armstrong remains a popular — if polarizing — figure, partly because of his charity work for cancer patients.

USADA's letter also said the agency was bringing doping charges against Johan Bruyneel, manager of Armstrong's winning teams; team doctors Pedro Celaya and Luis Garcia del Moral; team trainer Pepe Marti, and consulting doctor Michele Ferrari.

The USADA letter, a copy of which was obtained by The Associated Press, accuses Armstrong of using and promoting the use of the blood booster EPO, blood transfusions, testosterone, human growth hormone and anti-inflammatory steroids. The letter doesn't cite specific examples, but says the charges are based on evidence gathered in an investigation of Armstrong's teams, including interviews with witnesses who aren't named.

Cycling's governing body, the International Cycling Union, which collected the 2009 and 2010 samples cited in the USADA letter, said it was not involved in the anti-doping group's investigation.

According to USADA's letter, more than 10 cyclists as well as team employees will testify they either saw Armstrong dope or heard him tell them he used EPO, blood transfusions, testosterone and cortisone from 1996 to 2005. Armstrong won the Tour de France every year from 1999-2005.

During their investigation, federal prosecutors subpoenaed Armstrong supporters and ex-teammates to testify in Los Angeles. One of the most serious accusations came during a "60 Minutes" interview when former teammate Tyler Hamilton said he saw Armstrong use EPO during the 1999 Tour de France and in preparation for the 2000 and 2001 tours.

Early in the criminal investigation, Armstrong attorney's accused USADA of offering cyclists a "sweetheart deal" if they testify or provide evidence againstArmstrong.

In a letter to USADA last week, Armstrong attorney Robert Luskin noted that USADA Chief Executive Officer Travis Tygart participated in witness interviews with federal investigator Jeff Novitzky during the criminal probe.

"It is a vendetta, which has nothing to do with learning the truth and everything to do with settling a score and garnering publicity at Lance's expense," Luskin wrote.

In a statement, Tygart said, "USADA only initiates matters supported by the evidence. We do not choose whether or not we do our job based on outside pressures, intimidation or for any reason other than the evidence."

Armstrong has until June 29 to file a written response to the charges. The case could ultimately go before an arbitration panel to consider evidence. The USADA letter said in that case a hearing should be expected by November.

Armstrong, maintained his innocence, saying in his statement: "I have never doped, and, unlike many of my accusers, I have competed as an endurance athlete for 25 years with no spike in performance, passed more than 500 drug tests and never failed one. ...

"Any fair consideration of these allegations has and will continue to vindicate me."

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.
editor@csmonitor.com
Subscribe
Mark Sappenfield
Editor

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

Subscribe to insightful journalism

QR Code to New doping charges for Lance Armstrong
Read this article in
https://www.csmonitor.com/USA/Latest-News-Wires/2012/0613/New-doping-charges-for-Lance-Armstrong
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe